DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

Subtle Medical closes RSNA with CE mark and FDA clearance of PET AI solution Speeds up scans by factor of four, enhanced image quality

Siemens unveils syngo Virtual Cockpit software for CT, MR and PET at RSNA Offers remote expert technicians when needed

South African NTP Radioisotopes facility reopens following year-long closure Will help alleviate worldwide shortages of Mo-99 and other isotopes

Total-body PET scanner produces landmark human images First ever simultaneously captured 3-D image of the entire human body

Dr. Bernhard Sixt Edinburgh Molecular Imaging appoints as new Chief Executive Officer

TeamBest companies to acquire ABT Molecular Imaging, launch Best ABT Bringing greater expertise to smaller cyclotron technology

Missouri reactor becomes sole US domestic source of I-131 A vital radioisotope in the fight against thyroid cancer and hyperthyroidism

Cardinal Health to distribute IRE ELiT's 68-Ga generators Aiming to alleviate access shortages with Galli Eo generators

Zionexa partners with Columbia PET Center on development of EstroTep Identifies estrogen receptor status to diagnose metastatic breast cancer

Canada to build medical isotope research and development center Will act as a regional source for isotopes, including Tc-99m

Diseased mouse with atherosclerosis
viewed with optical and PET/CT imaging

PET/CT probe detects clogged arteries before atherosclerosis symptoms

by John W. Mitchell , Senior Correspondent
For the first time ever, a dual optical and PET/CT activity probe has identified clogged arteries in mice before the onset of atherosclerosis symptoms — a discovery made possible by the ability to target and image proteases, cells that are secreted by the agents which cause the disease.

"Atherosclerosis is one such disease where proteases are activated during inflammation and this activity is important for the pathology of the disease," Matthew Bogyo, Ph.D, one of the lead authors and professor in the Department of Pathology at Stanford University School of Medicine told HCB News. "My lab has been working on small molecule probes of proteases for a long time."

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



Those with a build-up of plaques in their arteries can go decades with no symptoms. The disease often does not announce itself until a stroke or heart attack occurs. Bogyo said their research in mice could eventually lead to diagnostic protocols to identify people who are at high risk for cardiovascular events.

"We hope that this reagent (probe) could be validated in human clinical trials soon and be used to specifically highlight ‘vulnerable’ plaques that are likely to rupture due to inflammation," said Bogyo.

The team's study was just published in the October issue of The Journal of Nuclear Medicine.

According to Bogyo, the team found that the probe — which is dual labeled with a fluorescent reporter and a radioactive tag that can be used for whole body non-invasive imaging — binds itself to the proteases at the site of inflammation in arteriosclerotic plaques.

"We demonstrated that this probe could be used to monitor plaques in a mouse model of the human disease," explained Bogyo. "It also could be used to label plaques isolated from human patients with atherosclerosis, confirming that the reporter works in humans."

The study demonstrated that targeting the proteases offers a rapid, non-invasive way to image atherosclerotic disease progression and plaque vulnerability. He sees broader uses for the probes in the future. This includes the ability to allow specific targeting of disease-associated proteins or markers that allow monitoring of disease onset, progress and response to therapeutic agents.

“The probes show efficacy in a variety of imaging modalities, including fluorescence, PET/CT, and topical application of the probe to fresh frozen murine and human tissue sections," said Bogyo.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED